Clinical Trial Update: Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR [EARLY_Phase 1]

View source ↗

Summary

Feasibility early-phase trial evaluating the F2 Filter and Delivery System for embolic protection during transcatheter aortic valve replacement (TAVR) for aorti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Drugs mentioned

• F2 Filter and Delivery System for Embolic Protection During TAVR

Snippet

Sponsor: EnCompass Technologies, Inc. | Conditions: Aortic Stenosis | EARLY_Phase 1 | Status: RECRUITING